CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-31 | Chhabra Meenu Director | Grant or award · Restricted Stock Unit | +4,500 | 4,500 | ||
| 2023-05-31 | Chhabra Meenu Director | Grant or award · Stock Option (right to buy) | +15,759 | 15,759 | ||
| 2023-05-31 | Chhabra Meenu Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2023-05-31 | O'Brien Federica F. Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 | ||
| 2023-05-31 | O'Brien Federica F. Director | Grant or award · Restricted Stock Unit | +4,500 | 4,500 | ||
| 2023-03-10 | Peters Jeffrey Stuart Senior VP and General Counsel | Sale | −5,372 | $6.03 | $32K | 0 |
| 2023-02-22 | Peters Jeffrey Stuart Senior VP and General Counsel | Exercise or conversion | +8,750 | 8,750 | ||
| 2023-02-22 | Peters Jeffrey Stuart Senior VP and General Counsel | Shares withheld for taxes | −3,378 | $6.55 | $22K | 5,372 |
| 2023-02-22 | Peters Jeffrey Stuart Senior VP and General Counsel | Exercise or conversion · Restricted Stock Unit | −8,750 | 0 | ||
| 2023-02-22 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion | +9,375 | 123,799 | ||
| 2023-02-22 | Bonvini Ezio Sr VP, Research & CSO | Shares withheld for taxes | −3,619 | $6.55 | $24K | 120,180 |
| 2023-02-22 | Bonvini Ezio Sr VP, Research & CSO | Exercise or conversion · Restricted Stock Unit | −9,375 | 0 | ||
| 2023-02-15 | Koenig Scott President and CEO | Grant or award · Employee stock option (right to buy) | +510,000 | 510,000 | ||
| 2023-02-15 | Koenig Scott President and CEO | Grant or award · Restricted Stock Unit | +127,000 | 127,000 | ||
| 2023-02-15 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Employee stock option (right to buy) | +170,000 | 170,000 | ||
| 2023-02-15 | Spitznagel Thomas Sr VP, Technical Ops | Grant or award · Restricted Stock Unit | +40,000 | 40,000 | ||
| 2023-02-15 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Employee stock option (right to buy) | +200,000 | 200,000 | ||
| 2023-02-15 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Restricted Stock Unit | +50,000 | 50,000 | ||
| 2023-02-15 | Peters Jeffrey Stuart Senior VP and General Counsel | Grant or award · Employee stock option (right to buy) | +170,000 | 170,000 | ||
| 2023-02-15 | Peters Jeffrey Stuart Senior VP and General Counsel | Grant or award · Restricted Stock Unit | +40,000 | 40,000 |
Page 19 of 26 · 503 trades